Browsing by author Branca, M. Subscribe author statistics Branca, M.
Showing results 1 to 12 of 12.
|May-2011||Co-factors of high-risk human papillomavirus infections display unique profiles in incident CIN1, CIN2 and CIN3||Syrjänen, K.; Shabalova, I.; Naud, P., et al.||Article||Restricted access (Author)|
|2005||Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study||Syrjänen, K.; Naud, P.; Derchain, S., et al.||Article||Restricted access (UMinho)|
|2012||Covariates of high-risk human papillomavirus (HPV) infections are distinct for incident CIN1, CIN2 and CIN3 as disclosed by competing-risks regression models||Syrjänen, K.; Shabalova, I.; Sarian, L. O., et al.||Article||Restricted access (UMinho)|
|Apr-2008||Drug addiction is not an independent risk factor for oncogenic human papillomavirus infections or high-grade cervical intraepithelial neoplasia: case-control study nested within the Latin American Screening study cohort||Syrjänen, K.; Naud, P.; Derchain, S., et al.||Article||Restricted access (Author)|
|Sep-2005||Evaluation of visual inspection with acetic acid (VIA), Lugol’s iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America||Sarian, L. O.; Derchain, S. F.; Naud, P., et al.||Article||Open access|
|2011||Hormonal contraceptives and the length of their use are not independent risk factors for high-risk HPV infections or high-grade CIN||Longatto Filho, Adhemar; Hammes, L. Serpa; Sarian, L., et al.||Article||Open access|
|2006||Human papillomavirus testing as an optional screening tool in low-resource settings of Latin America: experience from the Latin American Screening study||Longatto Filho, Adhemar; Eržen, M.; Branca, M., et al.||Article||Open access|
|Nov-2007||Interlaboratory quality control in gynecologic cytopathology using the novel conquistador software : interobserver reproducibility in the Latin American screening study||Alderisio, M.; Branca, M.; Eržen, M., et al.||Article||Open access|
|Oct-2012||Longitudinal outcomes of high-risk human papillomavirus (HPV) infections as competing-risks events following cervical HPV test at baseline visit in the *NIS-LAMS** cohort||Syrjänen, K.; Shabalova, I.; Sarian, L., et al.||Article||Restricted access (UMinho)|
|Jun-2011||Risk estimates for persistent high-risk human papillomavirus infections as surrogate endpoints of progressive cervical disease critically depend on reference category: analysis of the combined prospective cohort of the New Independent States of the Former Soviet Union and Latin American Screening Studies||Syrjänen, K.; Shabalova, I.; Naud, P., et al.||Article||Restricted access (Author)|
|2008||Safety of screening with Human papillomavirus testing for cervical cancer at three-year intervals in a high-risk population: experience from the LAMS study||Derchain, S. F.; Sarian, L. O.; Naud, P., et al.||Article||Open access|
|2008||Self-sampling for human papillomavirus (HPV) testing as cervical cancer screening option. Experience from the LAMS study||Longatto, Adhemar; Roteli-Martins, C.; Hammes, L., et al.||Article||Open access|